Medicare Enrolled
Dr. Mitchell Greenspan, MD
Cardiovascular Disease · Sellersville, PA
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Greenspan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Greenspan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Greenspan
Dr. Mitchell Greenspan is a cardiovascular disease specialist in Sellersville, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Greenspan performed 4,014 Medicare services across 2,247 unique beneficiaries.
Between the years covered by Open Payments, Dr. Greenspan received a total of $5,167 from 35 pharmaceutical and/or device companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Greenspan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in PA
$5,167 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,014
Medicare services
Top 14% in PA for cardiovascular disease
2,247
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~201 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
726 | $11 | $75 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
595 | $7 | $55 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
446 | $96 | $197 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
336 | $8 | $35 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
269 | $17 | $95 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
269 | $65 | $127 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
234 | $22 | $95 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
209 | $52 | $376 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
151 | $140 | $262 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
116 | $4 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
111 | $66 | $129 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
85 | $21 | $44 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
85 | $30 | $64 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
67 | $106 | $216 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
56 | $57 | $318 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
49 | $17 | $175 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
49 | $11 | $175 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
41 | $19 | $70 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
39 | $19 | $39 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
38 | $28 | $185 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
29 | $17 | $75 |
| New patient office visit, complex (60-74 min) | 14 | $184 | $325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.7% high complexity
3.8% medium
77.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,167
Total received (2018-2024)
Avg $738/year across 7 years
Top 33% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
261
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,167 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,209
2023
$763
2022
$438
2021
$569
2020
$238
2019
$957
2018
$992
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$211
Novartis Pharmaceuticals Corporation
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
Boston Scientific Corporation
$143
Merck Sharp & Dohme LLC
$109
Novo Nordisk Inc
$60
Kiniksa Pharmaceuticals International, plc
$56
PFIZER INC.
$52
Alnylam Pharmaceuticals Inc.
$49
Janssen Pharmaceuticals, Inc
$42
Philips North America LLC
$39
Lexicon Pharmaceuticals, Inc.
$38
Esperion Therapeutics, Inc.
$23
Medtronic, Inc.
$22
SCPHARMACEUTICALS INC.
$16
E.R. Squibb & Sons, L.L.C.
$15
SANOFI-AVENTIS U.S. LLC
$13
Top 3 companies account for 44.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$555
Novartis Pharmaceuticals Corporation
$542
Boehringer Ingelheim Pharmaceuticals, Inc.
$518
Janssen Pharmaceuticals, Inc
$371
Boston Scientific Corporation
$361
PFIZER INC.
$305
SANOFI-AVENTIS U.S. LLC
$303
Abbott Laboratories
$275
Medtronic, Inc.
$268
Medtronic Vascular, Inc.
$251
BOSTON SCIENTIFIC CORPORATION
$139
Alnylam Pharmaceuticals Inc.
$121
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$120
Merck Sharp & Dohme LLC
$109
Amgen Inc.
$107
E.R. Squibb & Sons, L.L.C.
$105
Novo Nordisk Inc
$78
Lundbeck LLC
$72
Kiniksa Pharmaceuticals International, plc
$56
Kestra Medical Technology Services, Inc.
$56
Regeneron Healthcare Solutions, Inc.
$52
ARALEZ PHARMACEUTICALS US INC.
$50
Amarin Pharma Inc.
$41
BIOTRONIK INC.
$40
Philips North America LLC
$39
Lexicon Pharmaceuticals, Inc.
$38
Lantheus Medical Imaging, Inc.
$34
Bayer HealthCare Pharmaceuticals Inc.
$31
Merck Sharp & Dohme Corporation
$29
Esperion Therapeutics, Inc.
$23
Philips Electronics North America Corporation
$21
Kiniksa Pharmaceuticals, Ltd.
$19
SCPHARMACEUTICALS INC.
$16
Kowa Pharmaceuticals America, Inc.
$11
iRhythm Technologies, Inc.
$11
Top 3 companies account for 31.3% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (CK4) MCOT · Adempas · Alere i · Arcalyst · Assure WCD · Azure · BRILINTA · BioMonitor · CAMZYOS · CHANTIX · CareLink · Confirm Rx · Corlanor · DEFINITY · Definity · ELIQUIS · ENTRESTO · EVKEEZA · Edora 8 DR-T · FARXIGA · FUROSCIX · GENERAL THERAPIES · HeartMate · HeartMate 3 Left Ventricular Assist Device · JARDIANCE · JOT DX · LEQVIO · LINQ II · LOKELMA · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MULTAQ · Mitra Clip system · NEXLETOL · NORTHERA · ONPATTRO · Ozempic · PRADAXA · PRALUENT · RESONATE · Repatha · Reveal LINQ · Rybelsus · SelectSecure · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
345
Per 100K population
53.4
County median income
$111,951
Nearest hospital
ST LUKE'S HOSPITAL - GRAND VIEW CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Greenspan is an electrophysiology & remote specialist, with above-average Medicare volume (top 14% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Greenspan experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Greenspan performed 726 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Greenspan receive payments from pharmaceutical companies?
Yes. Dr. Greenspan received a total of $5,167 from 35 companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Greenspan's costs compare to other cardiologists in Sellersville?
Dr. Greenspan's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Greenspan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Sellersville
Browse cardiologists in Sellersville ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology